Sterling Capital Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.11K Sell
324
-7
-2% -$166 ﹤0.01% 2488
2025
Q4
$8.71K Buy
331
+210
+174% +$4.58K ﹤0.01% 2676
2025
Q3
$2.07K Buy
121
+2
+2% +$29 ﹤0.01% 2973
2025
Q2
$1.49K Sell
119
-822
-87% -$9.79K ﹤0.01% 2990
2025
Q1
$11.2K Sell
941
-778
-45% -$10.6K ﹤0.01% 1829
2024
Q4
$25.2K Buy
1,719
+1,524
+782% +$21.3K ﹤0.01% 1805
2024
Q3
$2.45K Buy
+195
New +$2.12K ﹤0.01% 2093

Other funds holding ZYME

Sterling Capital Management's ZYME Position: Q1 2026 in Review

Sterling Capital Management reduced its Zymeworks (ZYME) stake by 2.1% in Q1 2026, selling an estimated $166 and leaving 324 shares worth $8.11K. The position accounts for ﹤0.01% of the portfolio, ranked #2488.

Sterling Capital Management first reported a position in ZYME in Q3 2024 and has held it in 7 quarters since. The position peaked at $25.2K in Q4 2024. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Sterling Capital Management held 324 shares of Zymeworks worth $8.11K as of Q1 2026.
  • Sterling Capital Management sold 7 Zymeworks shares in Q1 2026, an estimated $166.
  • Zymeworks made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2488 holding.
  • Sterling Capital Management first reported a position in Zymeworks in Q3 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's Zymeworks position peaked at $25.2K in Q4 2024.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.